Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today announced that the last patient has completed their final […]
Probiotics and Analytical Implications Probiotic products are booming all over the World, in a diversity of foods from yogurt to kefir, kimchi, kombucha, sauerkraut and enriched products as well as dietary supplements, with a global market […]
Some especially good work was published in the microbiome scientific literature this past month. Several of the papers below constitute important investigations that are likely to shape new areas of study or spur new medical […]
Millions of people take capsules of probiotics with the goal of improving their digestion, but what if those bacteria were also able to detect diseases in the gut and indicate when something is awry? New […]
Scientists are advancing our understanding of how the skin microbiome—the diverse community of bacteria, fungi, and other microbes living on the skin’s surface—is important for skin health. Knowing what shapes the skin microbiome may provide […]
The Microbiome Therapeutics Innovation Group (MTIG) announced today the appointment of a new chairman, Ken Blount, Ph.D., Chief Scientific Officer of Rebiotix, Inc. Dr. Blount replaces Tom DesRosier, Esq., Chief Legal Officer of Seres Therapeutics, […]
A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One. In a paper titled “The oral microbiome […]
Investment in the company’s microbiome platform will propel the global launch of breakthrough products for livestock, companion animal and human health: MicroSintesis, a life science company focused on developing proprietary microbiome therapies today, at the Vet […]
DayTwo, the microbiome human discovery platform that offers a glycemic control solution for people with type 2 diabetes, announced $31 Million in Series B financing. DayTwo will use the funding to accelerate go-to-market initiatives in […]
The human microbiome, the vast collection of microbes that colonize the surfaces lining many of our organs and our skin – is a critical pillar sustaining our general health. At any one time, 500 to […]